In addition, it has been shown that CA-MSCs can activate the expression level of sphingosine-1-phosphate receptor 1 (S1PR1) in neuroblastoma-related tumor cells and the downstream signaling pathway that functions through JAK2 and STAT3 (214). Here, JAK2 is linked to neoplasm.